 |
N-Hydroxy-4-(3-methyl-2-(S)phenyl-butyrylamino)benzamide |
|---|---|
| Trade Name | |
| Orphan Indication | Schwannoma |
| USA Market Approval | USA |
| USA Designation Date | 2012-01-13 00:00:00 |
| Sponsor | Arno Therapeutics, Inc.;200 Route 31 North, Suite 104;Flemington, New Jersey, 08822 |
